Immuneering (IMRX) Other Operating Expenses (2022 - 2026)

Immuneering's Other Operating Expenses history runs 5 years deep, the most recent figure standing at $7317.0 for Q1 2026.

• On a quarterly basis, Other Operating Expenses changed 0.0% year-over-year to $7317.0 in Q1 2026; TTM through Mar 2026 was $29268.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $29267.0, changed 0.0% from the prior year.
• Other Operating Expenses held at $7317.0 in Q1 2026 per IMRX's latest filing, from $7317.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $8103.0 in Q1 2022 and bottomed at $7316.0 in Q4 2022.
• The 5-year median for Other Operating Expenses is $7317.0 (2022), against an average of $7363.2.
• Biggest YoY gain for Other Operating Expenses was 0.01% in 2023; the steepest drop was 9.7% in 2023.
• Year by year, Other Operating Expenses stood at $7316.0 in 2022, then gained by 0.01% to $7317.0 in 2023, then changed by 0.0% to $7317.0 in 2024, then changed by 0.0% to $7317.0 in 2025, then changed by 0.0% to $7317.0 in 2026.
• Per Business Quant, the three latest IMRX Other Operating Expenses figures stand at $7317.0 (Q1 2026), $7317.0 (Q4 2025), and $7317.0 (Q3 2025).